View More View Less
  • 1 Zahedan University of Medical Sciences, Iran
  • | 2 Zahedan University of Medical Sciences, Iran
  • | 3 Zahedan University of Medical Sciences, Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Aim:

The aim of the present study was to find out the impact of fat mass and obesity-associated (FTO) gene on risk of pulmonary tuberculosis (PTB) in a sample of Iranian population.

Methods:

This case-control study was carried out on a total of 354 subjects including 185 PTB patients and 169 healthy subjects. Genotyping of FTO rs9939609 and rs8050136 variants was done using polymerase chain reaction-restriction fragment length polymorphism method.

Results:

FTO rs9939609 variant showed no statistically significant difference in allele and genotype frequencies between PTB patients and controls. The rs8050136 polymorphism marginally increased the risk of PTB in dominant (OR = 1.53, 95% CI = 1.00–2.33, p = 0.055, CA+AA vs. CC) inheritance model tested, where rs8050136 A allele significantly increased the risk of PTB (OR = 1.42, 95% CI = 1.02–1.97, p = 0.045) compared with C allele.

Conclusion:

The finding of the present study showed an association between FTO rs9939609 variant and risk of PTB. Further studies with larger sample sizes and different ethnicities are necessary to confirm the findings.

  • 1.

    Lin, P. L., Flynn, J. L.: Understanding latent tuberculosis: A moving target. J Immunol 185, 1522 (2010).

  • 2.

    Oxlade, O., Schwartzman, K., Behr, M. A., Benedetti, A., Pai, M., Heymann, J., Menzies, D.: Global tuberculosis trends: A reflection of changes in tuberculosis control or in population health? Int J Tuberc Lung Dis 13, 12381246 (2009).

    • Search Google Scholar
    • Export Citation
  • 3.

    Zumla, A., George, A., Sharma, V., Herbert, N., Baroness Masham of Ilton: WHO’s 2013 global report on tuberculosis: Successes, threats, and opportunities. Lancet 382, 17651767 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Hashemi, M., Sharifi-Mood, B., Nezamdoost, M., Moazeni-Roodi, A., Naderi, M., Kouhpayeh, H., Taheri, M., Ghavami, S.: Functional polymorphism of interferon-gamma (IFN-gamma) gene +874T/A polymorphism is associated with pulmonary tuberculosis in Zahedan, Southeast Iran. Prague Med Rep 112, 3843 (2011).

    • Search Google Scholar
    • Export Citation
  • 5.

    Hashemi, M., Sharifi-Mood, B., Rasouli, A., Amininia, S., Naderi, M., Taheri, M.: Macrophage migration inhibitory factor −173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran. EXCLI J 14, 117122 (2015).

    • Search Google Scholar
    • Export Citation
  • 6.

    Bahari, G., Hashemi, M., Taheri, M., Naderi, M., Eskandari-Nasab, E., Atabaki, M.: Association of IRGM polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan, Southeast Iran. Sci World J 2012, 950801 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Naderi, M., Hashemi, M., Hazire-Yazdi, L., Taheri, M., Moazeni-Roodi, A., Eskandari-Nasab, E., Bahari, G.: Association between toll-like receptor2 Arg677Trp and 597T/C gene polymorphisms and pulmonary tuberculosis in Zahedan, Southeast Iran. Braz J Infect Dis 15, 516520 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Naderi, M., Hashemi, M., Taheri, M., Pesarakli, H., Eskandari-Nasab, E., Bahari, G.: CD209 promoter −336 A/G (rs4804803) polymorphism is associated with susceptibility to pulmonary tuberculosis in Zahedan, southeast Iran. J Microbiol Immunol Infect 47, 171175 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Shamsi, M., Zolfaghari, M. R., Farnia, P.: Association of IFN-gamma and P2X7 receptor gene polymorphisms in susceptibility to tuberculosis among Iranian patients. Acta Microbiol Immunol Hung 63, 93101 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Fredriksson, R., Hagglund, M., Olszewski, P. K., Stephansson, O., Jacobsson, J. A., Olszewska, A. M., Levine, A. S., Lindblom, J., Schioth, H. B.: The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology 149, 20622071 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    de Heredia, F. P., Gomez-Martinez, S., Marcos, A.: Obesity, inflammation and the immune system. Proc Nutr Soc 71, 332338 (2012).

  • 12.

    Festa, A., D’Agostino, R., Jr., Williams, K., Karter, A. J., Mayer-Davis, E. J., Tracy, R. P., Haffner, S. M.: The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 14071415 (2001).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Bullo, M., Garcia-Lorda, P., Megias, I., Salas-Salvado, J.: Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 11, 525531 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Karlsson, E. A., Beck, M. A.: The burden of obesity on infectious disease. Exp Biol Med (Maywood) 235, 14121424 (2010).

  • 15.

    Choe, S. S., Huh, J. Y., Hwang, I. J., Kim, J. I., Kim, J. B.: Adipose tissue remodeling: Its role in energy metabolism and metabolic disorders. Front Endocrinol (Lausanne) 7, 30 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Ande, S. R., Nguyen, K. H., Gregoire Nyomba, B. L., Mishra, S.: Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC. Sci Rep 6, 23608 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Fawcett, K. A., Barroso, I.: The genetics of obesity: FTO leads the way. Trends Genet 26, 266274 (2010).

  • 18.

    Albuquerque, D., Nobrega, C., Manco, L.: Association of FTO polymorphisms with obesity and obesity-related outcomes in Portuguese children. PLoS One 8, e54370 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Attaoua, R., Ait El Mkadem, S., Lautier, C., Kaouache, S., Renard, E., Brun, J. F., Fedou, C., Gris, J. C., Bringer, J., Grigorescu, F.: Association of the FTO gene with obesity and the metabolic syndrome is independent of the IRS-2 gene in the female population of Southern France. Diabetes Metab 35, 476483 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Guclu-Geyik, F., Onat, A., Yuzbasiogullari, A. B., Coban, N., Can, G., Lehtimaki, T., Erginel-Unaltuna, N.: Risk of obesity and metabolic syndrome associated with FTO gene variants discloses clinically relevant gender difference among Turks. Mol Biol Rep 43, 485494 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Qi, L., Kang, K., Zhang, C., van Dam, R. M., Kraft, P., Hunter, D., Lee, C. H., Hu, F. B.: Fat mass-and obesity-associated (FTO) gene variant is associated with obesity: Longitudinal analyses in two cohort studies and functional test. Diabetes 57, 31453151 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Feng, Y., Wang, F., Pan, H., Qiu, S., Lu, J., Wu, L., Wang, J., Lu, C.: Obesity-associated gene FTO rs9939609 polymorphism in relation to the risk of tuberculosis. BMC Infect Dis 14, 592 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Kouhpayeh, H. R., Hashemi, M., Hashemi, S. A., Moazeni-Roodi, A., Naderi, M., Sharifi-Mood, B., Taheri, M., Mohammadi, M., Ghavami, S.: R620W functional polymorphism of protein tyrosine phosphatase non-receptor type 22 is not associated with pulmonary tuberculosis in Zahedan, Southeast Iran. Genet Mol Res 11, 10751081 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Hashemi, M., Hanafi Bojd, H., Eskandari Nasab, E., Bahari, A., Hashemzehi, N. A., Shafieipour, S., Narouie, B., Taheri, M., Ghavami, S.: Association of adiponectin rs1501299 and rs266729 gene polymorphisms with nonalcoholic fatty liver disease. Hepat Mon 13, e9527 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Huang, X., Zhao, J., Yang, M., Li, M., Zheng, J.: Association between FTO gene polymorphism (rs9939609 T/A) and cancer risk: A meta-analysis. Eur J Cancer Care (Engl) (2016).

    • Search Google Scholar
    • Export Citation
  • 26.

    Zhao, J., Huang, X., Yang, M., Li, M., Zheng, J.: Association between the FTOrs8050136 polymorphism and cancer risk: A meta-analysis. Fam Cancer 15, 145153 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 5 0 0
May 2021 2 0 0
Jun 2021 7 0 0
Jul 2021 9 0 0
Aug 2021 2 0 0
Sep 2021 5 0 0
Oct 2021 0 0 0